DE602005013788D1 - ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung - Google Patents

ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung

Info

Publication number
DE602005013788D1
DE602005013788D1 DE602005013788T DE602005013788T DE602005013788D1 DE 602005013788 D1 DE602005013788 D1 DE 602005013788D1 DE 602005013788 T DE602005013788 T DE 602005013788T DE 602005013788 T DE602005013788 T DE 602005013788T DE 602005013788 D1 DE602005013788 D1 DE 602005013788D1
Authority
DE
Germany
Prior art keywords
peptides
ckrox
analogs
treatment
skin aging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013788T
Other languages
English (en)
Inventor
Thierry Oddos
Gaelle Bellemere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DE602005013788D1 publication Critical patent/DE602005013788D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
DE602005013788T 2005-10-11 2005-10-11 ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung Active DE602005013788D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05292121A EP1775306B1 (de) 2005-10-11 2005-10-11 ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung

Publications (1)

Publication Number Publication Date
DE602005013788D1 true DE602005013788D1 (de) 2009-05-20

Family

ID=35717506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013788T Active DE602005013788D1 (de) 2005-10-11 2005-10-11 ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung

Country Status (7)

Country Link
US (1) US20100093637A1 (de)
EP (1) EP1775306B1 (de)
JP (1) JP2009511520A (de)
AT (1) ATE427956T1 (de)
CA (1) CA2624990A1 (de)
DE (1) DE602005013788D1 (de)
WO (1) WO2007042254A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2349972B1 (es) 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
US9173913B2 (en) 2010-08-19 2015-11-03 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9161958B2 (en) 2010-08-19 2015-10-20 Johnson & Johnson Consumer Inc. Methods of treating cellulite
US9168279B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising paulownin and/or Paulownia extracts and uses thereof
WO2012024395A2 (en) 2010-08-19 2012-02-23 Johnson & Johnson Consumer Companies Inc. Compositions comprising paulwnin and/or paulownia extracts and uses thereof
US9168207B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9168219B2 (en) 2010-08-19 2015-10-27 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
US9962326B2 (en) 2010-08-19 2018-05-08 Johnson & Johnson Consumer Inc. Compositions comprising paulownia tomentosa wood extracts and uses thereof
US9387349B2 (en) 2010-08-19 2016-07-12 Johnson & Johnson Consumer Inc. Compositions comprising Paulownia tomentosa wood extracts and uses thereof
KR101805690B1 (ko) * 2011-06-27 2018-01-10 (주)아모레퍼시픽 화장료 조성물을 포함하는 피부 미용 키트 및 도포방법
US9579278B2 (en) 2013-05-10 2017-02-28 Johnson & Johnson Consumer Inc. Compositions comprising extracts of Bursera simaruba
CA3127759A1 (en) 2019-01-24 2020-07-30 Council Of Scientific And Industrial Research Kit for detecting melanoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10508856A (ja) * 1994-11-15 1998-09-02 オスモティクス コーポレーション スキンケア組成物及びその適用方法
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery
US20030044787A1 (en) * 2000-05-16 2003-03-06 Joung J. Keith Methods and compositions for interaction trap assays
DE10100121A1 (de) * 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
KR20040062602A (ko) 2001-10-30 2004-07-07 펜타팜아게 피부약학적 및 화장품학적 활성 올리고펩타이드

Also Published As

Publication number Publication date
WO2007042254A1 (en) 2007-04-19
JP2009511520A (ja) 2009-03-19
ATE427956T1 (de) 2009-04-15
CA2624990A1 (en) 2007-04-19
US20100093637A1 (en) 2010-04-15
EP1775306A1 (de) 2007-04-18
EP1775306B1 (de) 2009-04-08

Similar Documents

Publication Publication Date Title
DE602005013788D1 (de) ckrox-Peptide und ihre Analoge zur Behandlung von Hautalterung
ATE534379T1 (de) Neue verwendung von peptid-verbindungen zur behandlung von muskelschmerzen
DE602006020898D1 (de) Peptide zur förderung des haarwachstums und zur verbesserung von falten und kosmetische zusammensetzungen, die diese enthalten
DE602005004139D1 (de) Verwendung von Salicyloyl-Sphingoidbase zur Behandlung oder Verhinderung von Cellilitis
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60335997D1 (de) Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
DE602006017071D1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
HK1063291A1 (en) Use of phaeodactylum algae extract to promote the proteasome activity of skin cells
DE602005025517D1 (de) Herstellung und anwendung von biphenyl-4-yl-carbonylaminosäurederivaten zur behandlung von obesitas
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE524479T1 (de) Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
EP2182006A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
ATE249220T1 (de) Verwendung von piperin und derivate davon zur behandlung von hautpigmentierungstörungen und hautkrebs
WO2009125925A3 (ko) 성장인자―미미킹 펩타이드 및 그의 용도
ATE473728T1 (de) Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare
EA200600996A1 (ru) Композиция для полезного воздействия на кожу с использованием ключевых промежуточных продуктов клеточного метаболизма
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
ATE460152T1 (de) Organosilikon-derivate von amino- hydroxybenzophenonen und ihre verwendung als uv-a-filter in kosmetischen zubereitungen
ATE546154T1 (de) Anti-angiogenetisches mittel und seine verwendung bei der krebsbehandlung
WO2011157609A3 (en) Use of amino acid derivatives as agents for treating human perspiration, peptide derivatives, and compositions containing them
ATE406868T1 (de) Verwendung einer zusammensetzung mit vitamin k1- oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition